Recombinant anti-human CD3 / CD3 bispecific antibodies share the variable region sequences with the mouse anti-human CD3 antibody (clone number: OKT3) and mouse anti-human CD3 antibody (clone number: UCHT1). The recombinant mouse IgG2a bispecific isotype...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: 29F.1A12) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: 29F.1A12) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD 1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-1 antibody (clone number: 29F.1A12). The recombinant mouse...
Recombinant anti-mouse PD 1 / PD 1 bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the rat anti-mouse PD-1 antibody (clone number: 29F.1A12). The recombinant mouse...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
The research grade Nimotuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2b isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
